FDA Draft Guidance for Developing Drugs for Early Stage Alzheimer's Disease

• By: fda
• Date: February 07, 2013
• Source: www.fda.gov

The draft guidance explains the FDA’s current thinking about the way researchers can identify and select patients with early Alzheimer’s disease, or those who are at risk of developing the disease, for participation in clinical trials.

Click here to download the file